Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein

被引:58
作者
Wang, Jun-Sheng [1 ,3 ]
Zhu, Hao-Jie [2 ]
Gibson, Bryan Bradford [1 ]
Markowitz, John Seth [2 ]
Donovan, Jennifer Lyn [1 ]
DeVane, Carl Lindsay [1 ]
机构
[1] Med Univ S Carolina, Dept Psychiat & Behav Sci, Lab Drug Disposit & Pharmacogenet, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
[3] Bristol Myers Squibb Co, Princeton, NJ 08540 USA
关键词
P-glycoprotein; sertraline; desmethylsertraline; bupropion; antidepressant; blood-brain barrier;
D O I
10.1248/bpb.31.231
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ATP-binding cassette (ABC) transporter protein subfamily B1 line (ABCB1) transporter P-glycoprotein (P-gp) plays an important role in the blood-brain barrier limiting a broad spectrum of substrates from entering the central nervous system. In the present study, the transport activity of P-gp for sertraline, desmethylsertralin, bupropion, and the major metabolites of bupropion, threo-amino alcohol (TB), erythro-amino alchhol (EB), and hydroxy metabolite (HB) was studied using an ATPase assay in expressed human P-gp membranes by measuring concentrations of inorganic Pi in expressed human P-gp membranes. Verapamil was included as a positive control. The Michaelis-Menten equation was used for characterizing the kinetic data. Sertraline and desmethylsertraline showed high affinity for P-gp. The V-max/K-m values of sertraline (1.6 min(-1) x 10(-3)) and desmethylsertraline (1.4 min(-1) x 10(-3)) were comparable with that of verapamil (1.7 min(-1) x 10(-3)). Bupropion and its three metabolites showed very weak affinity for P-gp, with V-max/K-m values lower than 0.01 min(-1) x 10(-3). The results of the present study indicate that sertraline and desmethylsertraline have high affinity for P-gp, whereas bupropion and its three major metabolites TB, EB, and HB have very weak affinity for P-gp. These findings may help to explain observed drug-drug interactions among antidepressants.
引用
收藏
页码:231 / 234
页数:4
相关论文
共 28 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   In vitro P-glycoprotein affinity for atypical and conventional antipsychotics [J].
Boulton, DW ;
DeVane, CL ;
Liston, HL ;
Markowitz, JS .
LIFE SCIENCES, 2002, 71 (02) :163-169
[3]  
Choo EF, 2000, DRUG METAB DISPOS, V28, P655
[4]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[5]  
Feighner JP, 1999, J CLIN PSYCHIAT, V60, P4
[6]   Placental passage of antidepressant medications [J].
Hendrick, V ;
Stowe, ZN ;
Altshuler, LL ;
Hwang, S ;
Lee, E ;
Haynes, D .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (05) :993-996
[7]   Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects [J].
Hogeland, G. W. ;
Swindells, S. ;
McNabb, J. C. ;
Kashuba, A. D. M. ;
Yee, G. C. ;
Lindley, C. M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) :69-75
[8]   A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin [J].
Juurlink, DN ;
Mamdani, MM ;
Kopp, A ;
Herrmann, N ;
Laupacis, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) :102-107
[9]   The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].
Kim, RB ;
Fromm, MF ;
Wandel, C ;
Leake, B ;
Wood, AJJ ;
Roden, DM ;
Wilkinson, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294
[10]   Intestinal drug transporters:: In vivo function and clinical importance [J].
Kunta, JR ;
Sinko, PJ .
CURRENT DRUG METABOLISM, 2004, 5 (01) :109-124